Results 151 to 160 of about 85,383 (302)

Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. [PDF]

Indian J Ophthalmol
Singh P, Garasiya T, Ajila V, Sengupta S, Datta A, Madhivanan N.   +5 more
europepmc   +1 more source

Lotilaner Ophthalmic Solution 0.25%: First Approval. [PDF]

Drugs, 2023
Syed YY.
europepmc   +1 more source

Hypertensive retinopathy in pre‐eclampsia and its association with disease severity and neonatal outcomes: A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Introduction Pre‐eclampsia (PE) involves systemic endothelial dysfunction and microvascular injury, yet routine obstetric care lacks noninvasive readouts of maternal microvascular health. We evaluated whether hypertensive retinopathy (HR) detected during pregnancy is associated with maternal disease severity and adverse neonatal outcomes ...
Gabriele Saccone, Francesco Matarazzo, Mariarosaria Motta, Marika Rovetto, Michele Rinaldi, Maurizio Guida, Ciro Costagliola   +6 more
wiley   +1 more source

Monocytes with trained immunity–like signatures are associated with acute anterior uveitis in ankylosing spondylitis

Interdisciplinary Medicine, EarlyView.
In ankylosing spondylitis‐acute anterior uveitis (AS‐AAU), trained immunity monocytes (Mono‐TI) differentiate into macrophages in the eye, retaining trained immunity features. Mono‐TI cells secrete pro‐inflammatory cytokines and chemokines, including IL‐1β, TNF‐α, and CCL3.
Yimeng Sun, Lu Zhang, Xinyu Yao, Yunfei Liu, Xin Li, Feng Wen, Yong Dai, Ye Dai, Ziyu Du, Dijie Qiao, Ziwei Meng, Cong Hu, Chun Yan, Wei Chi   +13 more
wiley   +1 more source

Diquafosol ophthalmic solution on ocular surface parameters in visual display terminal-associated dry eye disease. [PDF]

Int J Ophthalmol
Yang TT, Duan HY, Zhou YF, Ma BK, Zhao L, Lan QQ, Chen JW, Wang XY, Yoon KC, Qi H.   +9 more
europepmc   +1 more source

Colonic Barrier Dysfunction and Inflammation Induced by Nano‐/Micro‐Plastics Fibers in Mice via the FAK/NF‐κB/iNOS and TLR4/NF‐κB/iNOS Pathways

Journal of Applied Toxicology, EarlyView.
ABSTRACT As emerging environmental contaminants, nano‐ and micro‐plastics (NMPs) have drawn increasing research attention due to potential hazards to organisms. Particle shape is a key factor influencing the toxic effects of NMPs, and NMPs of different shapes cause varying degrees of tissue damage. We investigated the specific mechanisms of polystyrene
Yuting Li, Shibo Bao, Puyang Huang, Jiahui Wang, Hongfeng Li, Yahong Liu, Kai Wang, Jianjun Du, Lingjun Yan, Guowei Pan, Wei Sun   +10 more
wiley   +1 more source

Effects of Lotilaner Ophthalmic Solution, 0.25% on <i>Demodex</i> Blepharitis Patients with Meibomian Gland Disease. [PDF]

Clin Ophthalmol
Gupta PK, Gaddie IB, Shultz MC, Vollmer P, Silverstein SM, Shen Lee B, O'Dell L, Dhamdhere K, Yeu E.   +8 more
europepmc   +1 more source

Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval. [PDF]

Drugs, 2023
Syed YY.
europepmc   +1 more source

Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review

Journal of Clinical Laboratory Analysis, EarlyView.
Naganishia diffluens, a rare non‐neoformans cryptococcal species, was identified by PCR sequencing as the causative agent of oral cryptococcosis in a 31‐year‐old Iranian man with β‐thalassemia. This case represents the first documented instance of oral infection by N.
Zahra Yahyazadeh, Zeynab Haseli, Javad Javidnia, Mahdi Abastabar, Eisa Nazar, Hosein Jalali, Mohamad Taghi Hedayati, Hossein Karami, Mohsen Nosratabadi, Lotfollah Davoodi, Seyyed Reza Aghili, Maryam Moazeni, Iman Haghani, Hamid Badali   +13 more
wiley   +1 more source

Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. [PDF]

Indian J Ophthalmol
Singh P, Garasiya T, Ajila V, Sengupta S, Datta A, Nivean M.   +5 more
europepmc   +1 more source